192 related articles for article (PubMed ID: 27259840)
1. Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection.
Kaku N; Morinaga Y; Takeda K; Kosai K; Uno N; Hasegawa H; Miyazaki T; Izumikawa K; Mukae H; Yanagihara K
Int J Med Microbiol; 2016 Sep; 306(6):421-8. PubMed ID: 27259840
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection.
Yanagihara K; Kihara R; Araki N; Morinaga Y; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Tsukamoto K; Kamihira S
Int J Antimicrob Agents; 2009 Nov; 34(5):477-81. PubMed ID: 19665359
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.
Yamagishi Y; Mikamo H; Kato H; Nishiyama N; Asai N; Koizumi Y; Sakanashi D; Suematsu H; Matsuura K; Hagihara M
J Infect Chemother; 2017 Jun; 23(6):368-373. PubMed ID: 28343752
[TBL] [Abstract][Full Text] [Related]
4. Effects of Tedizolid Phosphate on Survival Outcomes and Suppression of Production of Staphylococcal Toxins in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia.
Le VT; Le HN; Pinheiro MG; Hahn KJ; Dinh ML; Larson KB; Flanagan SD; Badiou C; Lina G; Tkaczyk C; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137816
[TBL] [Abstract][Full Text] [Related]
5. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
6. Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
Burdette SD; Trotman R
Clin Infect Dis; 2015 Oct; 61(8):1315-21. PubMed ID: 26105167
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
Tessier PR; Keel RA; Hagihara M; Crandon JL; Nicolau DP
Antimicrob Agents Chemother; 2012 May; 56(5):2342-6. PubMed ID: 22354302
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Lepak AJ; Marchillo K; Pichereau S; Craig WA; Andes DR
Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
10. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Rybak JM; Marx K; Martin CA
Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
[TBL] [Abstract][Full Text] [Related]
11. Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
Jacqueline C; Broquet A; Roquilly A; Davieau M; Caillon J; Altare F; Potel G; Asehnoune K
J Infect Dis; 2014 Sep; 210(5):814-23. PubMed ID: 24620024
[TBL] [Abstract][Full Text] [Related]
12. Comparative Efficacies of Tedizolid Phosphate, Linezolid, and Vancomycin in a Murine Model of Subcutaneous Catheter-Related Biofilm Infection Due to Methicillin-Susceptible and -Resistant Staphylococcus aureus.
Bayer AS; Abdelhady W; Li L; Gonzales R; Xiong YQ
Antimicrob Agents Chemother; 2016 Aug; 60(8):5092-6. PubMed ID: 27297485
[TBL] [Abstract][Full Text] [Related]
13. Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate.
Xiao J; Gill C; Liang L; Liu J; Wu J; Feng HP; Flanagan S; Tan C; Flattery A
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373794
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.
Mikamo H; Takesue Y; Iwamoto Y; Tanigawa T; Kato M; Tanimura Y; Kohno S
J Infect Chemother; 2018 Jun; 24(6):434-442. PubMed ID: 29530544
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
[TBL] [Abstract][Full Text] [Related]
16. Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.
Gras J
Drugs Today (Barc); 2014 Nov; 50(11):729-37. PubMed ID: 25525633
[TBL] [Abstract][Full Text] [Related]
17. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
Luna CM; Bruno DA; García-Morato J; Mann KC; Risso Patrón J; Sagardía J; Absi R; García Bottino M; Marchetti D; Famiglietti A; Baleztena M; Biancolini C
Chest; 2009 Jun; 135(6):1564-1571. PubMed ID: 19141525
[TBL] [Abstract][Full Text] [Related]
18. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
[TBL] [Abstract][Full Text] [Related]
19. Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins.
Thomson KS; Goering RV
Antimicrob Agents Chemother; 2013 Jun; 57(6):2892-5. PubMed ID: 23571550
[TBL] [Abstract][Full Text] [Related]
20. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
